HCPLive Network

FDA Approval Delayed for Anti-clotting Agent Brilinta

FDA delays approval for anti-clotting drug Brilinta (ticagrelor)The FDA has again delayed approval for AstraZeneca’s blood thinner Brilinta (ticagrelor), asking the drug maker to supply additional information and analysis of data from the PLATO study.

According to a news release from AstraZeneca, the FDA issued a complete response letter (CRL) for the New Drug Application (NDA) for Brilinta that requested additional analyses of the PLATO data but “did not request that additional studies, including clinical studies, be conducted as a prerequisite for approval of the ticagrelor NDA.”

The news release says that although AZ is “evaluating the contents of the CRL and will respond to the agency's request for additional analyses of the PLATO data as soon as possible,” the company “remains confident in the NDA submission for ticagrelor and in its ability to respond to the agency's questions.”

Reports on this news have noted that Brilinta received marketing approval in Europe earlier this month, prompting speculation that the FDA would follow suit. With today’s announcement that has not proven to be the case, however. Speculation as to the nature of the FDA’s request for additional analysis of PLATO data has focused on concerns that “Brilinta doesn't work as well in American patients as it does in does in those overseas.” According to a FOX Business report, a brokerage Shore Capital note to investors said that “While it is difficult to speculate regarding the exact nature of the FDA's requests, there is a high likelihood that it will be regarding the data from the U.S. cohort and the role of high dose aspirin in generating the US. data.”

CardioBrief has a link to a report from a Leerink Swann research analyst that says “Unless FDA’s request for additional analysis is straightforward and can be turned around rapidly, we believe a 12-month delay is a realistic scenario for AZ assuming 6 months to submit the add’l and a subsequent 6 month review. Historical concerns and issues raised by the panel and FDA focused on the aberrant US and North American subset analyses which raised questions about (1) a potential interaction with high-dose aspirin; (2) an effect on statin metabolism; and (3) differences in treatment algorithm’s between the US and other markets that would result in diminished efficacy.”



Further Reading
Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.
Less than half of all Americans got a flu shot last year, so U.S. health officials on Thursday urged that everyone 6 months and older get vaccinated for the coming flu season. "It's really unfortunate that half of Americans are not getting the protection from flu they could get," said Thomas Frieden, MD, director of the U.S. Centers for Disease Control and Prevention, during a morning news conference.
Strategies are presented to help physicians lower their tax burden in an article published Sept. 2 in Medical Economics.
Trulicity (dulaglutide) is a once-weekly subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
The rate of major adverse cardiovascular events is higher in patients with diabetes mellitus and multivessel coronary artery disease treated with insulin versus those not treated with insulin, according to a study published in the Sept. 23 issue of the Journal of the American College of Cardiology.
For patients undergoing lumbar spine surgery, Clostridium difficile infection is associated with longer, more expensive hospital stays, and increased mortality, according to a study published in the Sept. 1 issue of Spine.
Patients diagnosed with type 1 diabetes have long known the benefits of ease and convenience that comes with using an insulin pump instead of relying on multiple daily insulin injections to control their condition. A recent study has shown that using a pump is also associated with positive effects on long-term cardiovascular risk and mortality.
More Reading